nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—ADRA2A—peripheral nervous system—Parkinson's disease	0.0106	0.0637	CbGeAlD
Phentolamine—ADRA1A—hindbrain—Parkinson's disease	0.00817	0.0489	CbGeAlD
Phentolamine—ADRA1D—forebrain—Parkinson's disease	0.00786	0.0471	CbGeAlD
Phentolamine—NISCH—medulla oblongata—Parkinson's disease	0.00681	0.0408	CbGeAlD
Phentolamine—NISCH—midbrain—Parkinson's disease	0.00622	0.0373	CbGeAlD
Phentolamine—NISCH—spinal cord—Parkinson's disease	0.00607	0.0364	CbGeAlD
Phentolamine—NISCH—cerebellum—Parkinson's disease	0.00481	0.0288	CbGeAlD
Phentolamine—ADRA1A—brainstem—Parkinson's disease	0.00468	0.028	CbGeAlD
Phentolamine—ADRA1B—head—Parkinson's disease	0.0046	0.0276	CbGeAlD
Phentolamine—ADRA1A—forebrain—Parkinson's disease	0.00452	0.0271	CbGeAlD
Phentolamine—ADRA1D—head—Parkinson's disease	0.0045	0.027	CbGeAlD
Phentolamine—ADRA1B—nervous system—Parkinson's disease	0.00436	0.0261	CbGeAlD
Phentolamine—ADRA1D—nervous system—Parkinson's disease	0.00427	0.0256	CbGeAlD
Phentolamine—ADRA1B—central nervous system—Parkinson's disease	0.0042	0.0252	CbGeAlD
Phentolamine—ADRA1D—central nervous system—Parkinson's disease	0.00411	0.0246	CbGeAlD
Phentolamine—SIGMAR1—medulla oblongata—Parkinson's disease	0.00396	0.0237	CbGeAlD
Phentolamine—NISCH—brain—Parkinson's disease	0.00391	0.0234	CbGeAlD
Phentolamine—ADRA1A—cardiovascular system—Parkinson's disease	0.00382	0.0229	CbGeAlD
Phentolamine—SIGMAR1—midbrain—Parkinson's disease	0.00362	0.0217	CbGeAlD
Phentolamine—SIGMAR1—spinal cord—Parkinson's disease	0.00353	0.0212	CbGeAlD
Phentolamine—ADRA2A—forebrain—Parkinson's disease	0.00343	0.0206	CbGeAlD
Phentolamine—ADRA1B—brain—Parkinson's disease	0.00334	0.02	CbGeAlD
Phentolamine—ADRA1D—brain—Parkinson's disease	0.00326	0.0196	CbGeAlD
Phentolamine—ADRA2C—medulla oblongata—Parkinson's disease	0.00311	0.0186	CbGeAlD
Phentolamine—ADRA2C—midbrain—Parkinson's disease	0.00284	0.017	CbGeAlD
Phentolamine—SIGMAR1—cerebellum—Parkinson's disease	0.0028	0.0168	CbGeAlD
Phentolamine—ADRA2C—spinal cord—Parkinson's disease	0.00277	0.0166	CbGeAlD
Phentolamine—ADRA1A—head—Parkinson's disease	0.00259	0.0155	CbGeAlD
Phentolamine—ADRA2A—medulla oblongata—Parkinson's disease	0.00248	0.0149	CbGeAlD
Phentolamine—ADRA2C—head—Parkinson's disease	0.00246	0.0148	CbGeAlD
Phentolamine—ADRA1A—nervous system—Parkinson's disease	0.00245	0.0147	CbGeAlD
Phentolamine—ADRA1A—central nervous system—Parkinson's disease	0.00236	0.0141	CbGeAlD
Phentolamine—ADRA2C—nervous system—Parkinson's disease	0.00234	0.014	CbGeAlD
Phentolamine—ADRA1A—cerebellum—Parkinson's disease	0.00231	0.0138	CbGeAlD
Phentolamine—SIGMAR1—brain—Parkinson's disease	0.00227	0.0136	CbGeAlD
Phentolamine—ADRA2A—midbrain—Parkinson's disease	0.00227	0.0136	CbGeAlD
Phentolamine—ADRA2C—central nervous system—Parkinson's disease	0.00225	0.0135	CbGeAlD
Phentolamine—ADRA2A—spinal cord—Parkinson's disease	0.00221	0.0133	CbGeAlD
Phentolamine—ADRA2C—cerebellum—Parkinson's disease	0.0022	0.0132	CbGeAlD
Phentolamine—ADRA2A—head—Parkinson's disease	0.00197	0.0118	CbGeAlD
Phentolamine—ADRA1A—brain—Parkinson's disease	0.00187	0.0112	CbGeAlD
Phentolamine—ADRA2A—nervous system—Parkinson's disease	0.00186	0.0112	CbGeAlD
Phentolamine—ADRA2A—central nervous system—Parkinson's disease	0.00179	0.0108	CbGeAlD
Phentolamine—ADRA2C—brain—Parkinson's disease	0.00179	0.0107	CbGeAlD
Phentolamine—ADRA2A—cerebellum—Parkinson's disease	0.00175	0.0105	CbGeAlD
Phentolamine—ADRA2A—brain—Parkinson's disease	0.00143	0.00854	CbGeAlD
Phentolamine—ADRA1B—GPCR downstream signaling—HTR7—Parkinson's disease	0.000262	0.000314	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—DRD2—Parkinson's disease	0.000258	0.00031	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—HTR7—Parkinson's disease	0.000258	0.00031	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—DRD3—Parkinson's disease	0.000257	0.000308	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—GRK5—Parkinson's disease	0.000257	0.000308	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000255	0.000306	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—DDC—Parkinson's disease	0.000253	0.000303	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—EDN1—Parkinson's disease	0.000252	0.000303	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—TAC1—Parkinson's disease	0.000251	0.000302	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—HTR1A—Parkinson's disease	0.000249	0.000299	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000249	0.000299	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—GRM4—Parkinson's disease	0.000248	0.000297	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—GFAP—Parkinson's disease	0.000247	0.000297	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—DRD1—Parkinson's disease	0.000247	0.000296	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PDYN—Parkinson's disease	0.000246	0.000295	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—TAC1—Parkinson's disease	0.000246	0.000295	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000245	0.000294	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—GRM5—Parkinson's disease	0.000245	0.000294	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PDYN—Parkinson's disease	0.000242	0.00029	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—DRD2—Parkinson's disease	0.000241	0.00029	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—HTR7—Parkinson's disease	0.000241	0.00029	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—DRD1—Parkinson's disease	0.000241	0.000289	CbGpPWpGaD
Phentolamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.00024	0.000289	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00024	0.000288	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—DRD3—Parkinson's disease	0.000239	0.000287	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GSTA4—Parkinson's disease	0.000239	0.000287	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—FGF20—Parkinson's disease	0.000238	0.000285	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—DRD2—Parkinson's disease	0.000238	0.000285	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—HTR7—Parkinson's disease	0.000238	0.000285	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PENK—Parkinson's disease	0.000235	0.000282	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MAG—Parkinson's disease	0.000235	0.000282	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—DRD3—Parkinson's disease	0.000233	0.00028	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—DRD2—Parkinson's disease	0.000232	0.000279	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—HTR7—Parkinson's disease	0.000232	0.000279	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—HTR1A—Parkinson's disease	0.000232	0.000278	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—GFAP—Parkinson's disease	0.000231	0.000277	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—ADORA2A—Parkinson's disease	0.00023	0.000277	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—GRM4—Parkinson's disease	0.00023	0.000276	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—EDN1—Parkinson's disease	0.000229	0.000275	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—GRM5—Parkinson's disease	0.000229	0.000274	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—TAC1—Parkinson's disease	0.000228	0.000274	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—EDN1—Parkinson's disease	0.000228	0.000274	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—GFAP—Parkinson's disease	0.000227	0.000273	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—GRM5—Parkinson's disease	0.000225	0.00027	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—DRD1—Parkinson's disease	0.000224	0.000269	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000223	0.000268	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000221	0.000265	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MAG—Parkinson's disease	0.000218	0.000262	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PENK—Parkinson's disease	0.000218	0.000262	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000218	0.000262	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—DRD3—Parkinson's disease	0.000217	0.00026	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—HTR7—Parkinson's disease	0.000216	0.000259	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—DRD2—Parkinson's disease	0.000216	0.000259	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PLA2G6—Parkinson's disease	0.000215	0.000258	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PDYN—Parkinson's disease	0.000215	0.000258	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—FGF20—Parkinson's disease	0.000215	0.000257	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—EDN1—Parkinson's disease	0.000213	0.000255	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—MAOB—Parkinson's disease	0.000213	0.000255	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—INSR—Parkinson's disease	0.000213	0.000255	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—HTR7—Parkinson's disease	0.000211	0.000253	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—DRD2—Parkinson's disease	0.000211	0.000253	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—EDN1—Parkinson's disease	0.000209	0.000251	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—ADORA2A—Parkinson's disease	0.000208	0.00025	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—EDN1—Parkinson's disease	0.000207	0.000248	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000202	0.000243	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—GFAP—Parkinson's disease	0.000202	0.000243	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—FGB—Parkinson's disease	0.000201	0.000241	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—HTR2A—Parkinson's disease	0.0002	0.000241	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—FGF20—Parkinson's disease	0.0002	0.000241	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—HTR1A—Parkinson's disease	0.0002	0.00024	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—GRM5—Parkinson's disease	0.0002	0.00024	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PDYN—Parkinson's disease	0.0002	0.00024	CbGpPWpGaD
Phentolamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.0002	0.00024	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000199	0.000239	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—FGF20—Parkinson's disease	0.000197	0.000237	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TAC1—Parkinson's disease	0.000197	0.000236	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—HTR7—Parkinson's disease	0.000196	0.000235	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—DRD2—Parkinson's disease	0.000196	0.000235	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CYP2D6—Parkinson's disease	0.000195	0.000234	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—ADORA2A—Parkinson's disease	0.000194	0.000233	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—EDN1—Parkinson's disease	0.000193	0.000232	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—DRD1—Parkinson's disease	0.000193	0.000232	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—INSR—Parkinson's disease	0.000192	0.00023	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—ADORA2A—Parkinson's disease	0.000191	0.00023	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CTGF—Parkinson's disease	0.000191	0.000229	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—EDN1—Parkinson's disease	0.00019	0.000228	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—GFAP—Parkinson's disease	0.000188	0.000225	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—DRD3—Parkinson's disease	0.000187	0.000224	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000186	0.000223	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—EDN1—Parkinson's disease	0.000186	0.000223	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—GRM5—Parkinson's disease	0.000186	0.000223	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000183	0.00022	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—FGB—Parkinson's disease	0.000181	0.000218	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—HTR2A—Parkinson's disease	0.000181	0.000217	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—HTR1A—Parkinson's disease	0.00018	0.000217	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—INSR—Parkinson's disease	0.000179	0.000215	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CYP2E1—Parkinson's disease	0.000178	0.000214	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TAC1—Parkinson's disease	0.000178	0.000213	CbGpPWpGaD
Phentolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000177	0.000213	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—INSR—Parkinson's disease	0.000176	0.000212	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—NQO1—Parkinson's disease	0.000176	0.000211	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—FGF20—Parkinson's disease	0.000175	0.00021	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—ADRBK1—Parkinson's disease	0.000175	0.00021	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—DRD1—Parkinson's disease	0.000174	0.000209	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—TH—Parkinson's disease	0.000174	0.000208	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—EDN1—Parkinson's disease	0.000173	0.000208	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ADORA2A—Parkinson's disease	0.00017	0.000204	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—FGB—Parkinson's disease	0.000169	0.000203	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—HTR7—Parkinson's disease	0.000169	0.000203	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—DRD2—Parkinson's disease	0.000169	0.000203	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—HTR2A—Parkinson's disease	0.000169	0.000203	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—EDN1—Parkinson's disease	0.000169	0.000203	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—DRD3—Parkinson's disease	0.000169	0.000203	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—HTR1A—Parkinson's disease	0.000169	0.000202	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—FGB—Parkinson's disease	0.000167	0.0002	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CYCS—Parkinson's disease	0.000167	0.0002	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—HTR2A—Parkinson's disease	0.000166	0.0002	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TAC1—Parkinson's disease	0.000166	0.000199	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—HTR1A—Parkinson's disease	0.000166	0.000199	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TAC1—Parkinson's disease	0.000163	0.000196	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—DRD1—Parkinson's disease	0.000163	0.000195	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000163	0.000195	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—FGF20—Parkinson's disease	0.000163	0.000195	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—DRD1—Parkinson's disease	0.00016	0.000192	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CYP2D6—Parkinson's disease	0.000158	0.00019	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ADORA2A—Parkinson's disease	0.000158	0.000189	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—DRD3—Parkinson's disease	0.000158	0.000189	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—ADRBK1—Parkinson's disease	0.000158	0.000189	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—EDN1—Parkinson's disease	0.000157	0.000188	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—INSR—Parkinson's disease	0.000157	0.000188	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CTGF—Parkinson's disease	0.000155	0.000186	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—DRD3—Parkinson's disease	0.000155	0.000186	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—DRD2—Parkinson's disease	0.000153	0.000183	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—HTR7—Parkinson's disease	0.000153	0.000183	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000151	0.000182	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—FGB—Parkinson's disease	0.000148	0.000178	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—HTR2A—Parkinson's disease	0.000148	0.000177	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—COMT—Parkinson's disease	0.000148	0.000177	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HTR1A—Parkinson's disease	0.000147	0.000177	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—ADRBK1—Parkinson's disease	0.000147	0.000177	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—GSTP1—Parkinson's disease	0.000147	0.000176	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—MAOA—Parkinson's disease	0.000147	0.000176	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—INSR—Parkinson's disease	0.000146	0.000175	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TAC1—Parkinson's disease	0.000145	0.000174	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—ADRBK1—Parkinson's disease	0.000145	0.000174	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—HMOX1—Parkinson's disease	0.000145	0.000174	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CYP2E1—Parkinson's disease	0.000145	0.000174	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—NQO1—Parkinson's disease	0.000143	0.000172	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—HTR7—Parkinson's disease	0.000143	0.000171	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—DRD2—Parkinson's disease	0.000143	0.000171	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—DRD1—Parkinson's disease	0.000142	0.000171	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IGF2—Parkinson's disease	0.000142	0.00017	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—TH—Parkinson's disease	0.000141	0.000169	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—HTR7—Parkinson's disease	0.00014	0.000168	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—DRD2—Parkinson's disease	0.00014	0.000168	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—ABCB1—Parkinson's disease	0.000139	0.000167	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	0.000138	0.000165	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—FGB—Parkinson's disease	0.000138	0.000165	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—HTR2A—Parkinson's disease	0.000137	0.000165	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IGF1R—Parkinson's disease	0.000137	0.000164	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HTR1A—Parkinson's disease	0.000137	0.000164	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—EDN1—Parkinson's disease	0.000135	0.000163	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CYCS—Parkinson's disease	0.000135	0.000162	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—GSTM1—Parkinson's disease	0.000135	0.000162	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TAC1—Parkinson's disease	0.000135	0.000162	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—DRD1—Parkinson's disease	0.000132	0.000159	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—GPX1—Parkinson's disease	0.000129	0.000155	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	0.000129	0.000155	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—DRD3—Parkinson's disease	0.000128	0.000154	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IGF2—Parkinson's disease	0.000128	0.000154	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	0.000125	0.00015	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	0.000125	0.00015	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NGF—Parkinson's disease	0.000124	0.000149	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IGF1R—Parkinson's disease	0.000124	0.000148	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—EDN1—Parkinson's disease	0.000122	0.000147	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—COMT—Parkinson's disease	0.00012	0.000144	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	0.00012	0.000144	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IGF2—Parkinson's disease	0.00012	0.000143	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GSTP1—Parkinson's disease	0.000119	0.000143	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—MTHFR—Parkinson's disease	0.000119	0.000143	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—MAOA—Parkinson's disease	0.000119	0.000143	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—HTR2A—Parkinson's disease	0.000118	0.000142	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—HMOX1—Parkinson's disease	0.000118	0.000141	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IGF2—Parkinson's disease	0.000118	0.000141	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	0.000116	0.000139	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	0.000116	0.000139	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IGF1R—Parkinson's disease	0.000116	0.000139	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—EDN1—Parkinson's disease	0.000114	0.000137	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IGF1R—Parkinson's disease	0.000114	0.000137	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ABCB1—Parkinson's disease	0.000113	0.000136	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—EDN1—Parkinson's disease	0.000112	0.000135	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NGF—Parkinson's disease	0.000112	0.000135	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—APOE—Parkinson's disease	0.000111	0.000133	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—APOE—Parkinson's disease	0.00011	0.000132	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GSTM1—Parkinson's disease	0.00011	0.000132	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—HTR2A—Parkinson's disease	0.000107	0.000128	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GPX1—Parkinson's disease	0.000105	0.000126	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NGF—Parkinson's disease	0.000105	0.000126	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	0.000104	0.000125	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	0.000103	0.000124	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	0.000101	0.000121	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—HTR2A—Parkinson's disease	9.99e-05	0.00012	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	9.98e-05	0.00012	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	9.94e-05	0.000119	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	9.83e-05	0.000118	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	9.71e-05	0.000117	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—MTHFR—Parkinson's disease	9.69e-05	0.000116	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—INS—Parkinson's disease	9.49e-05	0.000114	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—INS—Parkinson's disease	9.41e-05	0.000113	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	9.39e-05	0.000113	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—APOE—Parkinson's disease	9.29e-05	0.000111	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	9.27e-05	0.000111	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	9.17e-05	0.00011	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	9.14e-05	0.00011	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—APOE—Parkinson's disease	9.02e-05	0.000108	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	8.73e-05	0.000105	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	8.52e-05	0.000102	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—INS—Parkinson's disease	8.49e-05	0.000102	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	8.12e-05	9.74e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	8.11e-05	9.74e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—INS—Parkinson's disease	7.93e-05	9.52e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—INS—Parkinson's disease	7.81e-05	9.37e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—INS—Parkinson's disease	7.71e-05	9.25e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	7.54e-05	9.05e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CASP3—Parkinson's disease	7e-05	8.41e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—IL6—Parkinson's disease	6.96e-05	8.35e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—INS—Parkinson's disease	6.93e-05	8.32e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—INS—Parkinson's disease	6.44e-05	7.73e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MAPK8—Parkinson's disease	6.44e-05	7.73e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	6.32e-05	7.59e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	6.28e-05	7.54e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CASP3—Parkinson's disease	5.91e-05	7.09e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL6—Parkinson's disease	5.87e-05	7.04e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	5.81e-05	6.98e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	5.81e-05	6.98e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	5.78e-05	6.93e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MAPK8—Parkinson's disease	5.43e-05	6.52e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	5.34e-05	6.41e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	5.16e-05	6.2e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	5.13e-05	6.16e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	4.8e-05	5.76e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	4.77e-05	5.72e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	4.75e-05	5.7e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	4.41e-05	5.29e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL6—Parkinson's disease	4.11e-05	4.93e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	3.71e-05	4.45e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL6—Parkinson's disease	3.47e-05	4.16e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	3.41e-05	4.09e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	3.03e-05	3.64e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	2.82e-05	3.38e-05	CbGpPWpGaD
